62 related articles for article (PubMed ID: 8257635)
21. Activation of HIV-1 enhancer sequence by vaccinia virus.
Adachi A; Oshima Y; Koyama AH
Int J Mol Med; 1999 Mar; 3(3):311-3. PubMed ID: 10028058
[TBL] [Abstract][Full Text] [Related]
22. Short communication: a single step assay for rapid evaluation of inhibitors targeting HIV type 1 Tat-mediated long terminal repeat transactivation.
Chande AG; Baba M; Mukhopadhyaya R
AIDS Res Hum Retroviruses; 2012 Aug; 28(8):902-6. PubMed ID: 21878060
[TBL] [Abstract][Full Text] [Related]
23. An in vitro transcription system that recapitulates equine infectious anemia virus tat-mediated inhibition of human immunodeficiency virus type 1 Tat activity demonstrates a role for positive transcription elongation factor b and associated proteins in the mechanism of Tat activation.
Suñé C; Goldstrohm AC; Peng J; Price DH; Garcia-Blanco MA
Virology; 2000 Sep; 274(2):356-66. PubMed ID: 10964778
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of HIV-1 transcription and virus replication using soluble Tat peptide analogs.
Kashanchi F; Sadaie MR; Brady JN
Virology; 1997 Jan; 227(2):431-8. PubMed ID: 9018142
[TBL] [Abstract][Full Text] [Related]
25. Cationic liposome-mediated uptake of human immunodeficiency virus type 1 Tat protein into cells.
Fong SE; Smanik P; Smith MC; Jaskunas SR
J Virol Methods; 1997 Jun; 66(1):149-57. PubMed ID: 9220401
[TBL] [Abstract][Full Text] [Related]
26. Bovine immunodeficiency virus tat gene: cloning of two distinct cDNAs and identification, characterization, and immunolocalization of the tat gene products.
Fong SE; Greenwood JD; Williamson JC; Derse D; Pallansch LA; Copeland T; Rasmussen L; Mentzer A; Nagashima K; Tobin G; Gonda MA
Virology; 1997 Jul; 233(2):339-57. PubMed ID: 9217057
[TBL] [Abstract][Full Text] [Related]
27. Block of Tat-mediated transactivation of tumor necrosis factor beta gene expression by polymeric-TAR decoys.
Brother MB; Chang HK; Lisziewicz J; Su D; Murty LC; Ensoli B
Virology; 1996 Aug; 222(1):252-6. PubMed ID: 8806505
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional but not translational regulation of HIV-1 by the tat gene product.
Rice AP; Mathews MB
Nature; 1988 Apr; 332(6164):551-3. PubMed ID: 2833703
[TBL] [Abstract][Full Text] [Related]
29. The acidic amino-terminal region of the HIV-1 Tat protein constitutes an essential activating domain.
Rappaport J; Lee SJ; Khalili K; Wong-Staal F
New Biol; 1989 Oct; 1(1):101-10. PubMed ID: 2562188
[TBL] [Abstract][Full Text] [Related]
30. Replication of HIV type 1 in rabbit cell lines is not limited by deficiencies in tat, rev, or long terminal repeat function.
Cho S; Kindt TJ; Zhao TM; Sawasdikosol S; Hague BF
AIDS Res Hum Retroviruses; 1995 Dec; 11(12):1487-93. PubMed ID: 8679293
[TBL] [Abstract][Full Text] [Related]
31. Basal and Tat-transactivated expression from the human immunodeficiency virus type 1 long terminal repeat in human placental trophoblast rules out promoter-enhancer activation as the partial block to viral replication.
Zachar V; Ebbesen P; Thomas RA; Zacharova V; Goustin AS
J Gen Virol; 1994 Jun; 75 ( Pt 6)():1461-8. PubMed ID: 8207411
[TBL] [Abstract][Full Text] [Related]
32. Transcription of the HIV-1 LTR is regulated by the density of DNA CpG methylation.
Gutekunst KA; Kashanchi F; Brady JN; Bednarik DP
J Acquir Immune Defic Syndr (1988); 1993 Jun; 6(6):541-9. PubMed ID: 8496786
[TBL] [Abstract][Full Text] [Related]
33. An autocrine loop of HIV type-1 Tat protein responsible for the improved survival/proliferation capacity of permanently Tat-transfected cells and required for optimal HIV-1 LTR transactivating activity.
Zauli G; La Placa M; Vignoli M; Re MC; Gibellini D; Furlini G; Milani D; Marchisio M; Mazzoni M; Capitani S
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Nov; 10(3):306-16. PubMed ID: 7552492
[TBL] [Abstract][Full Text] [Related]
34. Paracrine activation of the HIV-1 LTR promoter by the viral Tat protein is mechanistically similar to trans-activation within a cell.
Verhoef K; Klein A; Berkhout B
Virology; 1996 Nov; 225(2):316-27. PubMed ID: 8918918
[TBL] [Abstract][Full Text] [Related]
35. Green fluorescence protein as a transcriptional reporter for the long terminal repeats of the human immunodeficiency virus type 1.
Kar-Roy A; Dong W; Michael N; Li Y
J Virol Methods; 2000 Feb; 84(2):127-38. PubMed ID: 10680962
[TBL] [Abstract][Full Text] [Related]
36. Human immunodeficiency virus type 1 tat gene enhances human papillomavirus early gene expression.
Tornesello ML; Buonaguro FM; Beth-Giraldo E; Giraldo G
Intervirology; 1993; 36(2):57-64. PubMed ID: 8294182
[TBL] [Abstract][Full Text] [Related]
37. Alterations in tumor angiogenesis associated with stable expression of the HIV tat gene.
Huber BE; Richards CA; Martin JL; Wirth PJ
Mol Carcinog; 1992; 5(4):293-300. PubMed ID: 1379815
[TBL] [Abstract][Full Text] [Related]
38. A microtransfection method using the luciferase-encoding reporter gene for the assay of human immunodeficiency virus LTR promoter activity.
Schwartz O; Virelizier JL; Montagnier L; Hazan U
Gene; 1990 Apr; 88(2):197-205. PubMed ID: 2189784
[TBL] [Abstract][Full Text] [Related]
39. New insights into the mechanism of HIV-1 trans-activation.
Karn J; Graeble MA
Trends Genet; 1992 Nov; 8(11):365-8. PubMed ID: 1440870
[No Abstract] [Full Text] [Related]
40. Inhibition of HIV type 1 Tat-mediated trans-activation by oncostatin M in HLtat cells.
Esté JA; Witvrouw M; Tu J; Desmyter J; De Clercq E; Vandamme AM
AIDS Res Hum Retroviruses; 1995 Nov; 11(11):1355-8. PubMed ID: 8573392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
